Dark

NKTR
Nektar Therapeutics
stock NASDAQ

At Close

Aug 20, 2026 3:59:55 PM EDT

74.53USD-2.037%(-1.55)438,448

74.39Bid 84.62Ask 10.23Spread

Pre-market

Aug 20, 2026 9:18:30 AM EDT

77.17USD+1.433%(+1.09)4,618

After-hours

Aug 20, 2026 4:00:30 PM EDT

74.53USD0.000%(0.00)59,180

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

2.54B

CEO

Howard Robin

Headquarters

San Francisco, California, USA

Industry

Biotechnology

Last Split

Jun 9, 20251for15reverse

AMGN RELL AZN NVS BAX JNJ PFE MRK ALKS XLV

NKTR Stats

Avg. Vol. 10 Day

609,495

Avg. Vol. 30 Day

682,883

Employees

509

Market Cap

2,543,653,053

Shares Out.

34,142,994

On/Off Exchange

60%/40%

6 Month Beta

1.02

1 Year Beta

1.20

2 Year Beta

1.81

3 Year Beta

1.81

52 Week Low

25.34

52 Week High

109.00

SMA50

68.65

SMA200

63.95

1 Week

-1.87%

1 Month

+14.90%

3 Month

+7.21%

6 Month

+1.04%

1 Year

+176.44%

2 Year

+288.02%

5 Year

-63.51%

Profile

nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.

NKTR Stock Summary

Nektar Therapeutics (NASDAQ:NKTR) stock price today is $74.53, and today's volume is 438,448. NKTR is down -2.037% today. The 30 day average volume is 682,883. NKTR market cap is 2.54B with 34,142,994 shares outstanding.

document.getElementById("KW8T1Z").onerror = function(){this.style.display='none';}; .dark-mode .BN9DrH{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .BN9DrH{ color: #333333; background-color: white; border: 2px solid #333333; }NKTRNektar Therapeuticsstock NASDAQ

NKTR Stock Summary

NKTR
Nektar Therapeutics
stock NASDAQ